(MedPage Today) — The FDA approved lerodalcibep (Lerochol) injections for the treatment of elevated LDL cholesterol in adults, maker LIB Therapeutics announced.
A third-generation PCSK9 inhibitor, lerodalcibep is indicated as an adjunct to diet…
Source link : https://www.medpagetoday.com/cardiology/dyslipidemia/119050
Author :
Publish date : 2025-12-16 20:00:00
Copyright for syndicated content belongs to the linked Source.
